VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
2.780
+0.056 (2.06%)
Apr 28, 2026, 4:00 PM EDT - Market closed
VolitionRx Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for VolitionRx stock have an average target of 1.67, with a low estimate of 1.00 and a high estimate of 3.00. The average target predicts a decrease of -39.93% from the current stock price of 2.78.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VolitionRx stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $1 | Strong Buy | Maintains | $1.5 → $1 | -64.03% | Apr 2, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +7.91% | Mar 31, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +7.91% | Mar 26, 2026 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $3 | Strong Buy | Maintains | $3 | +7.91% | Mar 18, 2026 |
Financial Forecast
Revenue This Year
7.87M
from 1.73M
Increased by 355.66%
Revenue Next Year
74.70M
from 7.87M
Increased by 849.08%
EPS This Year
-0.10
from -0.22
EPS Next Year
0.18
from -0.10
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 30.7M | 144.3M | ||||||
| Avg | 7.9M | 74.7M | ||||||
| Low | 1.9M | 8.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1,678.8% | 1,733.6% | ||||||
| Avg | 355.7% | 849.1% | ||||||
| Low | 8.4% | 12.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 0.07 | 0.77 | ||||||
| Avg | -0.10 | 0.18 | ||||||
| Low | -0.15 | -0.13 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.